EP3687532A4 - Compositions et méthodes de prévention/traitement du syndrome métabolique - Google Patents

Compositions et méthodes de prévention/traitement du syndrome métabolique Download PDF

Info

Publication number
EP3687532A4
EP3687532A4 EP18861957.1A EP18861957A EP3687532A4 EP 3687532 A4 EP3687532 A4 EP 3687532A4 EP 18861957 A EP18861957 A EP 18861957A EP 3687532 A4 EP3687532 A4 EP 3687532A4
Authority
EP
European Patent Office
Prior art keywords
compositions
preventing
methods
metabolic syndrome
treating metabolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18861957.1A
Other languages
German (de)
English (en)
Other versions
EP3687532A1 (fr
Inventor
Stephanie Lynch
Jack C. CAPPOZZO
Roger L. Dake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Dehydrated Foods Inc
Original Assignee
International Dehydrated Foods Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Dehydrated Foods Inc filed Critical International Dehydrated Foods Inc
Publication of EP3687532A1 publication Critical patent/EP3687532A1/fr
Publication of EP3687532A4 publication Critical patent/EP3687532A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
    • A23L13/50—Poultry products, e.g. poultry sausages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP18861957.1A 2017-09-28 2018-09-28 Compositions et méthodes de prévention/traitement du syndrome métabolique Pending EP3687532A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762564406P 2017-09-28 2017-09-28
PCT/US2018/053437 WO2019067908A1 (fr) 2017-09-28 2018-09-28 Compositions et méthodes de prévention/traitement du syndrome métabolique

Publications (2)

Publication Number Publication Date
EP3687532A1 EP3687532A1 (fr) 2020-08-05
EP3687532A4 true EP3687532A4 (fr) 2021-03-24

Family

ID=65902090

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18861957.1A Pending EP3687532A4 (fr) 2017-09-28 2018-09-28 Compositions et méthodes de prévention/traitement du syndrome métabolique

Country Status (4)

Country Link
EP (1) EP3687532A4 (fr)
CA (1) CA3073750A1 (fr)
MX (1) MX2020003102A (fr)
WO (1) WO2019067908A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150011500A1 (en) * 2013-07-08 2015-01-08 International Dehydrated Foods, Inc. Compositions Prepared From Poultry And Methods Of Their Use
WO2016123053A1 (fr) * 2015-01-26 2016-08-04 International Dehydrated Foods, Inc. Compositions de bouillon et leur utilisation en tant que prébiotiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4078431B2 (ja) * 2004-10-29 2008-04-23 国立大学法人九州工業大学 水溶性エラスチンとその製造方法及びそれを含む食品と医薬
JP4750213B1 (ja) * 2010-05-21 2011-08-17 株式会社 ファイナルフューチャーインターナショナル アディポネクチン産生促進組成物
WO2012170782A2 (fr) * 2011-06-10 2012-12-13 The Board Of Trustees Of The Leland Stanford Junior University Production de protéines recombinantes hydroxylées post-traductionnellement dans des bactéries

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150011500A1 (en) * 2013-07-08 2015-01-08 International Dehydrated Foods, Inc. Compositions Prepared From Poultry And Methods Of Their Use
WO2016123053A1 (fr) * 2015-01-26 2016-08-04 International Dehydrated Foods, Inc. Compositions de bouillon et leur utilisation en tant que prébiotiques

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; April 2016 (2016-04-01), DURHAM PAUL ET AL: "Biochemical Comparison of AAC1 Enriched Chicken Broth to Homemade Chicken Broth: Potential Benefits to Joint Health", XP002802057, Database accession no. PREV201700780497 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; April 2016 (2016-04-01), DURHAM PAUL ET AL: "Chicken Broth AAC1 as a Dietary Supplement Inhibits Pain Transmission and Decreases Serum C-Reactive Protein Levels In a Model of TMJ Disorder", XP002802058, Database accession no. PREV201700785733 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; April 2016 (2016-04-01), HAWKINS JORDAN ET AL: "Inclusion of Chicken Broth AAC1 as a Dietary Supplement Modulates the Gut Microbiome: Results of Next-Generation DNA Sequencing", XP002802056, Database accession no. PREV201700785189 *
DE COSSÍO LOURDES FERNÁNDEZ ET AL: "Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome", BRAIN, BEHAVIOR AND IMMUNITY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 64, 24 December 2016 (2016-12-24), pages 33 - 49, XP085091753, ISSN: 0889-1591, DOI: 10.1016/J.BBI.2016.12.022 *
JILL A. PARNELL ET AL: "Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome", GUT MICROBES, vol. 3, no. 1, 1 January 2012 (2012-01-01), pages 29 - 34, XP055080951, ISSN: 1949-0976, DOI: 10.4161/gmic.19246 *
See also references of WO2019067908A1 *

Also Published As

Publication number Publication date
WO2019067908A1 (fr) 2019-04-04
EP3687532A1 (fr) 2020-08-05
MX2020003102A (es) 2020-07-28
CA3073750A1 (fr) 2019-04-04

Similar Documents

Publication Publication Date Title
EP3607072A4 (fr) Compositions et méthodes de traitement de la phénylcétonurie
EP3585433A4 (fr) Compositions thérapeutiques et méthodes associées pour la photoimmunothérapie
EP3328376A4 (fr) Méthodes et compositions pour le traitement de troubles de la reprogrammation métabolique
EP3612215A4 (fr) Compositions et procédés pour le traitement d'inflammation pulmonaire
EP3634424A4 (fr) Compositions et procédés pour prévenir ou traiter des affections musculaires
EP3645739A4 (fr) Procédés et compositions pour le traitement du mélanome
EP3704227A4 (fr) Composition et procédé
EP3423100A4 (fr) Compositions destinées à traiter l'inflammation et méthodes de traitement associées
EP3189074A4 (fr) Compositions et méthodes pour traiter et prévenir l'inflammation
EP3261644A4 (fr) Compositions et méthodes pour le traitement de dégradations de la rétine
EP3720421A4 (fr) Compositions et méthodes pour le traitement d'affections métaboliques
EP3706558A4 (fr) Compositions et procédés d'aquaculture
EP3193903A4 (fr) Compositions et méthodes permettant le traitement d'un syndrome d'irradiation aiguë
EP3801478A4 (fr) Méthodes et compositions pour la prévention ou le traitement de la calciphylaxie
EP3658142A4 (fr) Compositions et méthodes de traitement de la galactosémie
EP3687628A4 (fr) Compositions et méthodes pour inhiber acss2
EP3691649A4 (fr) Compositions et méthodes de traitement des plaies
EP3262065A4 (fr) Procédés et compositions de traitement des dystroglycanopathies
EP3411367A4 (fr) Compositions et méthodes de traitement d'infections bactériennes
EP3341006A4 (fr) Compositions et méthodes pour le traitement d'une lésion neurologique
EP3618846A4 (fr) Procédés et compositions pour traiter une maladie hépatique
EP3600291A4 (fr) Compositions et méthodes de traitement des synucléinopathies
AU2018301500A1 (en) Methods and compositions for treating inflammation
EP3595640A4 (fr) Compositions et procédés de traitement de la sclérose en plaques
EP3638287A4 (fr) Méthodes et compositions pour le traitement d'une inflammation microbienne

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200312

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210219

RIC1 Information provided on ipc code assigned before grant

Ipc: A23L 33/10 20160101ALI20210212BHEP

Ipc: A23L 13/50 20160101ALI20210212BHEP

Ipc: A61K 31/401 20060101AFI20210212BHEP

Ipc: A61P 3/10 20060101ALI20210212BHEP

Ipc: A23L 33/175 20160101ALI20210212BHEP

Ipc: A61K 35/57 20150101ALI20210212BHEP

Ipc: A23L 33/00 20160101ALI20210212BHEP

Ipc: A61K 31/4172 20060101ALI20210212BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20220218

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20231006